Inventor · disambiguated record
Masanobu Nagano
Also filed as: NAGANO MASANOBU
11 granted patents·194 citations·filing 1980–1998
91Inventor score
Files withFUJISAWA PHARMACEUTICAL CO11
Top patents by PatentIndex Score
11 records- 0195US4563455AAntiulcer fused imidazole compoundsFUJISAWA PHARMACEUTICAL CO·Filed 1984·Granted Jan 7, 1986·40 cites·7 claims
- 0294US4377580ATricyclic quinazoline derivativesFUJISAWA PHARMACEUTICAL CO·Filed 1980·Granted Mar 22, 1983·34 cites·10 claims
- 0384US6025375A4,5-diaryloxazole derivativesFUJISAWA PHARMACEUTICAL CO·Filed 1998·Granted Feb 15, 2000·36 cites·19 claims
- 0484US4831041AImidazopyridine compounds and processes for preparation thereofFUJISAWA PHARMACEUTICAL CO·Filed 1987·Granted May 16, 1989·20 cites·13 claims
- 0581US4920129AAnti-ulcerative imidazopyridine compoundsFUJISAWA PHARMACEUTICAL CO·Filed 1988·Granted Apr 24, 1990·29 cites·14 claims
- 0675US4429126ASodium salt of 4-oxo-10-(2,3-dimethylpentanamido)-4H-pyrimido[1,2-c]quinozoline-3-carboxylic acidFUJISAWA PHARMACEUTICAL CO·Filed 1982·Granted Jan 31, 1984·8 cites·1 claims
- 0770US5763489ANaphthalene derivatives as prostaglandin I2 agonsistsFUJISAWA PHARMACEUTICAL CO·Filed 1995·Granted Jun 9, 1998·11 cites·13 claims
- 0859US5863918ANaphthalene derivativesFUJISAWA PHARMACEUTICAL CO·Filed 1998·Granted Jan 26, 1999·6 cites·12 claims
- 0948US4564621Aα-Aryl-α-pyridylalkanoic acid derivatives, process for preparation thereof and pharmaceutical composition comprising the sameFUJISAWA PHARMACEUTICAL CO·Filed 1983·Granted Jan 14, 1986·3 cites·5 claims
- 1046US5387710AEthanolamine derivatives having sympathomimetic and anti-pollakiuria activitiesFUJISAWA PHARMACEUTICAL CO·Filed 1993·Granted Feb 7, 1995·6 cites·7 claims
- 1144US4543356AQuinazoline derivativesFUJISAWA PHARMACEUTICAL CO·Filed 1983·Granted Sep 24, 1985·1 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Masanobu Nagano files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →